Form 4 for KVYO Klaviyo, Inc.
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001991399-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-17 | 2024-05-15 | KVYO | Edmond Landon | CLO | C - Cnv Deriv | — | +16.7K | 291.7K | +6% | — |
| D | 2024-05-17 | 2024-05-15 | KVYO | Edmond Landon | CLO | F - Tax | $24.80 | -25.8K | 266.0K | -9% | -$639.5K |
| D | 2024-05-17 | 2024-05-15 | KVYO | Edmond Landon | CLO | C - Cnv Deriv | $0.00 | -16.7K | 305.3K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2024-05-15 | C | A | 16,666 | — | 291,749 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 2 | Common | Series A Common Stock | 2024-05-15 | F | D | 25,788 | $24.80 | 265,961 | D | — | — | (F3) Consists of (i) 11,002 shares of Series A Common Stock and (ii) 254,959 unvested RSUs awarded under the Issuer's 2023 Stock Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| 3 | Derivative | Series B Common Stock | 2024-05-15 | C | D | 16,666 | $0.00 | 305,253 | D | — · — to — | 16,666 Series A Common Stock | (F4) Consists of (i) 141,986 shares of Series B Common Stock and (ii) 163,267 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |